153 related articles for article (PubMed ID: 11068591)
1. [For which tumor entities are effects of overall treatment time on the results of radiotherapy evident?].
Stuschke M; Marnitz S; Wurm R; Budach V
Strahlenther Onkol; 2000 Oct; 176(10):462-5. PubMed ID: 11068591
[TBL] [Abstract][Full Text] [Related]
2. [The time factor in oncological therapy].
Baumann M; Herrmann T
Strahlenther Onkol; 2000 Oct; 176(10):441-2. PubMed ID: 11068586
[No Abstract] [Full Text] [Related]
3. [Split-course radiotherapy or treatment interruption].
Feldmann HJ
Strahlenther Onkol; 2000 Oct; 176(10):458-61. PubMed ID: 11068590
[TBL] [Abstract][Full Text] [Related]
4. Hyperfractionated or accelerated radiotherapy for head and neck cancer.
Baujat B; Bourhis J; Blanchard P; Overgaard J; Ang KK; Saunders M; Le Maître A; Bernier J; Horiot JC; Maillard E; Pajak TF; Poulsen MG; Bourredjem A; O'Sullivan B; Dobrowsky W; Andrzej H; Skladowski K; Hay JH; Pinto LH; Fu KK; Fallai C; Sylvester R; Pignon JP;
Cochrane Database Syst Rev; 2010 Dec; 2010(12):CD002026. PubMed ID: 21154350
[TBL] [Abstract][Full Text] [Related]
5. Altered fractionation in definitive irradiation of squamous cell carcinoma of the head and neck.
Mendenhall WM; Amdur RJ; Siemann DW; Parsons JT
Curr Opin Oncol; 2000 May; 12(3):207-14. PubMed ID: 10841192
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of modified fractionation radiotherapy versus conventional radiotherapy for unresected non-small-cell lung cancer patients.
Ramaekers BL; Joore MA; Lueza B; Bonastre J; Mauguen A; Pignon JP; Le Pechoux C; De Ruysscher DK; ; Grutters JP
J Thorac Oncol; 2013 Oct; 8(10):1295-307. PubMed ID: 24457241
[TBL] [Abstract][Full Text] [Related]
7. Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials.
Stuschke M; Thames HD
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):259-67. PubMed ID: 9069295
[TBL] [Abstract][Full Text] [Related]
8. Dose and Fractionation in Radiation Therapy of Curative Intent for Non-Small Cell Lung Cancer: Meta-Analysis of Randomized Trials.
Ramroth J; Cutter DJ; Darby SC; Higgins GS; McGale P; Partridge M; Taylor CW
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):736-747. PubMed ID: 27639294
[TBL] [Abstract][Full Text] [Related]
9. Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis.
Mauguen A; Le Péchoux C; Saunders MI; Schild SE; Turrisi AT; Baumann M; Sause WT; Ball D; Belani CP; Bonner JA; Zajusz A; Dahlberg SE; Nankivell M; Mandrekar SJ; Paulus R; Behrendt K; Koch R; Bishop JF; Dische S; Arriagada R; De Ruysscher D; Pignon JP
J Clin Oncol; 2012 Aug; 30(22):2788-97. PubMed ID: 22753901
[TBL] [Abstract][Full Text] [Related]
10. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers.
Dobrowsky W; Naudé J
Radiother Oncol; 2000 Nov; 57(2):119-24. PubMed ID: 11054514
[TBL] [Abstract][Full Text] [Related]
11. Altered radiotherapy fractionation: an opportunity not to be missed.
Benson RJ; Burnet NG
Clin Oncol (R Coll Radiol); 1998; 10(3):150-4. PubMed ID: 9704175
[No Abstract] [Full Text] [Related]
12. Altered fractionation radiotherapy in head and neck squamous cell carcinoma.
Mallick S; Benson R; Julka PK; Rath GK
J Egypt Natl Canc Inst; 2016 Jun; 28(2):73-80. PubMed ID: 26994645
[TBL] [Abstract][Full Text] [Related]
13. Radiation therapy for non-small cell lung cancer (NSCLC).
Choy H; Chakravarthy A; Kim JS
Cancer Treat Res; 2001; 105():121-48. PubMed ID: 11224985
[No Abstract] [Full Text] [Related]
14. Systematic Review and Meta-analysis of Conventionally Fractionated Concurrent Chemoradiotherapy versus Altered Fractionation Radiotherapy Alone in the Definitive Management of Locoregionally Advanced Head and Neck Squamous Cell Carcinoma.
Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):50-61. PubMed ID: 26454839
[TBL] [Abstract][Full Text] [Related]
15. Comparison of conventional fractionation (five fractions per week) and altered fractionation (six fractions per week) in stage I and II squamous cell carcinoma of oropharynx: An institutional study.
Poddar J; Sharma AD; Kunikullaya SU; Neema JP
Indian J Cancer; 2017; 54(1):6-10. PubMed ID: 29199652
[TBL] [Abstract][Full Text] [Related]
16. Modified fractionated radiotherapy in head and neck squamous cell carcinoma (HNSCC) & re-irradiation in recurrent head and neck carcinomas.
De Crevoisier R; Bourhis J; Eschwège F
Cancer Treat Res; 2003; 114():199-212. PubMed ID: 12619542
[No Abstract] [Full Text] [Related]
17. Updated data for chart in NSCLC: a missed opportunity.
Rowell NP
Radiother Oncol; 2000 Apr; 55(1):85-7. PubMed ID: 10885970
[No Abstract] [Full Text] [Related]
18. A systematic overview of radiation therapy effects in head and neck cancer.
Zackrisson B; Mercke C; Strander H; Wennerberg J; Cavallin-Ståhl E
Acta Oncol; 2003; 42(5-6):443-61. PubMed ID: 14596506
[TBL] [Abstract][Full Text] [Related]
19. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.
Bourhis J; Overgaard J; Audry H; Ang KK; Saunders M; Bernier J; Horiot JC; Le Maître A; Pajak TF; Poulsen MG; O'Sullivan B; Dobrowsky W; Hliniak A; Skladowski K; Hay JH; Pinto LH; Fallai C; Fu KK; Sylvester R; Pignon JP;
Lancet; 2006 Sep; 368(9538):843-54. PubMed ID: 16950362
[TBL] [Abstract][Full Text] [Related]
20. Biological factors influencing optimum fractionation in radiation therapy.
Fowler JF
Acta Oncol; 2001; 40(6):712-7. PubMed ID: 11765065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
